SGLT2 Inhibitors Treatment Market Share

North America Market Analysis

North America is estimated to have the highest revenue share of 32% during the forecast period. With the increasing prevalence of obesity and lifestyle changes in the region, chronic diseases are growing on a yearly basis. Approximately 50 % of Americans suffer from at least one chronic disease every year. Additionally, it is predicted that the region's high healthcare spending will spur market expansion. According to data from the World Bank, the area of North America spent 16.415% of its total GDP on healthcare.

Asia Pacific Market Analysis

Asia Pacific region is expected to witness the fastest growth of 8.35% during the forecast period.  The factors such as rising disposable income, increasing social organization awareness, improving health care facilities, and more R&D activities are expected to drive the growth of the market in the Asia-pacific region.